Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Locarnini

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Clinical Microbiology|November 1, 1983
Monoclonal antibodies against hepatitis A virusA MacGregor, M Kornitschuk, J G Hurrell, et al.
The Medical Journal of Australia|October 7, 1996
Prevalence of hepatitis G virus in Queensland blood donorsL D Moaven, C A Hyland, I F Young, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionL J Stuyver, S A Locarnini, A Lok, et al.
The Medical Journal of Australia|July 19, 1993
A case of acute hepatitis E in VictoriaL D Moaven, A J Fuller, J C Doultree, et al.
Nucleosides & Nucleotides|August 5, 1999
Comparison of anti-HBV activity of beta-D- and beta-L-DDA-5'monophosphate prodrugs and effectiveness in combination with lamivudineA G Loi, A Faraj, C Pierra, et al.
The Medical Journal of Australia|March 20, 1995
Locally acquired hepatitis E in the Northern Territory of AustraliaT C Heath, J N Burrow, B J Currie, et al.
HIV Medicine|January 31, 2009
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutationsJ Audsley, N Arrifin, L K W Yuen, et al.
Journal of Hepatology|November 19, 1997
Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infectionL D Moaven, S A Locarnini, D S Bowden, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 5, 1999
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulinG W McCaughan, J Spencer, D Koorey, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2014
Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flareV Nguyen, P K Tan, A-J Greenup, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Clinical Microbiology|November 1, 1983
Monoclonal antibodies against hepatitis A virusA MacGregor, M Kornitschuk, J G Hurrell, et al.
The Medical Journal of Australia|October 7, 1996
Prevalence of hepatitis G virus in Queensland blood donorsL D Moaven, C A Hyland, I F Young, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionL J Stuyver, S A Locarnini, A Lok, et al.
The Medical Journal of Australia|July 19, 1993
A case of acute hepatitis E in VictoriaL D Moaven, A J Fuller, J C Doultree, et al.
Nucleosides & Nucleotides|August 5, 1999
Comparison of anti-HBV activity of beta-D- and beta-L-DDA-5'monophosphate prodrugs and effectiveness in combination with lamivudineA G Loi, A Faraj, C Pierra, et al.
The Medical Journal of Australia|March 20, 1995
Locally acquired hepatitis E in the Northern Territory of AustraliaT C Heath, J N Burrow, B J Currie, et al.
HIV Medicine|January 31, 2009
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutationsJ Audsley, N Arrifin, L K W Yuen, et al.
Journal of Hepatology|November 19, 1997
Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infectionL D Moaven, S A Locarnini, D S Bowden, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 5, 1999
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulinG W McCaughan, J Spencer, D Koorey, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2014
Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flareV Nguyen, P K Tan, A-J Greenup, et al.
Pageof 9